Clinical features of schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's Syndrome)

被引:15
|
作者
Miyaoka, T [1 ]
Yasukawa, R [1 ]
Mizuno, S [1 ]
Sukegawa, T [1 ]
Inagaki, T [1 ]
Horiguchi, J [1 ]
机构
[1] Shimane Med Univ, Dept Psychiat, Izumo, Shimane 6938501, Japan
关键词
schizophrenia; hyperbilirubinemia; Gilbert's syndrome; clinical features;
D O I
10.1080/13651500310001455
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
INTRODUCTION: Schizophrenic patients show a significantly higher frequency of hyperbilirubinemia than patients suffering from other psychiatric disorders and the general healthy population. To determine whether patients with schizophrenia-associated idiopathic unconjugated hyperbilirubinemia ( Gilbert's syndrome, GS) have a specific clinical character, various clinical assessments were performed. METHOD: Thirty-three schizophrenic patients with GS and 33 schizophrenic patients without GS were clinically assessed. The symptom profile, level of functioning, and extrapyramidal symptoms were evaluated by means of the Positive and Negative Syndrome Scale (PANSS), Brief Psychiatric Rating Scale (BPRS), Global Assessment of Functioning Scale (GAF), Chouinard Extrapyramidal Symptom Rating Scale (ESRS), Abnormal Involuntary Movement Scale ( AIMS), Drug-Induced Extra-Pyramidal Symptoms Scale ( DIEPSS), and Prins Henrry Hospital Akathisia Scale ( PHAS). RESULTS: In the acute phase, positive and general PANSS scores were significantly higher in schizophrenic patients with GS than without GS. However, there was no difference between schizophrenic subjects with GS and without GS on the negative symptom subscale. Moreover, in evaluation by BPRS and GAF, there was a significant difference between the two groups. In the stable phase, all subscales of PANSS scores were significantly higher in schizophrenic patients with GS than without GS. Similarly, there were significant differences between schizophrenic patients with GS and without GS on the BPRS and GAF. All scores of the rating scale of extrapyramidal symptoms were significantly higher in schizophrenic patients with GS than without GS. CONCLUSION: These findings suggest that there are significant clinical character differences between schizophrenic patients with GS and without GS. From the viewpoint of the heterogeneity of schizophrenia, there may be a poor outcome for the subtype of schizophrenia with GS than without GS.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [41] "Gilbert's-like" syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients
    Ye, Jin
    Cui, Lianlian
    Zhou, Yingqiao
    Huang, Ying
    Banafa, Omar
    Hou, Xiaohua
    Ding, Zhen
    Lin, Rong
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [42] Hyperbilirubinemia and Gilbert's syndrome in Thalassemia major and intermedia
    Galanello, R
    Cipollina, L
    Barella, LS
    Giagu, L
    Lai, E
    Cao, A
    [J]. BLOOD, 1997, 90 (10) : 572 - 572
  • [43] Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
    Rotger, M
    Taffé, P
    Bleiber, G
    Günthard, HF
    Furrer, H
    Vernazza, P
    Drechsler, H
    Bernasconi, E
    Rickenbach, M
    Telenti, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (08): : 1381 - 1386
  • [44] Doxorubicin dosage guidelines in a patient with hyperbilirubinemia of Gilbert's syndrome
    Cupp, MJ
    Higa, GM
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (10) : 1026 - 1029
  • [45] Hyperbilirubinemia in thalassemia intermedia. Relationship with Gilbert's syndrome
    Ferrara, M
    Ponte, G
    Matarese, SMR
    Francese, M
    Napoli, G
    Gangone, F
    Esposito, L
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 53 - 53
  • [46] Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism
    Xu, C.
    Reck, B.
    Xue, Z.
    Huang, L.
    Baker, K.
    Chen, M.
    Mooser, V.
    Cardon, L.
    Spraggs, C.
    Pandite, L.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 119 - 119
  • [47] Hyperbilirubinemia in Lapatinib Treated Patients Is Associated with Gilbert's Syndrome UGT1A1 Polymorphism
    Spraggs, C.
    Budde, L. R.
    Briley, L. P.
    Bing, N.
    Newstat, B.
    Rappold, E.
    Mooser, V
    Cardon, L. R.
    Stein, S.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 574S - 574S
  • [48] Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism
    C-F Xu
    B H Reck
    Z Xue
    L Huang
    K L Baker
    M Chen
    E P Chen
    H E Ellens
    V E Mooser
    L R Cardon
    C F Spraggs
    L Pandite
    [J]. British Journal of Cancer, 2010, 102 : 1371 - 1377
  • [49] Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism
    Xu, C-F
    Reck, B. H.
    Xue, Z.
    Huang, L.
    Baker, K. L.
    Chen, M.
    Chen, E. P.
    Ellens, H. E.
    Mooser, V. E.
    Cardon, L. R.
    Spraggs, C. F.
    Pandite, L.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (09) : 1371 - 1377
  • [50] Hyperbilirubinemia in pyruvate kinase deficiency: The role of Gilbert's syndrome.
    Sampietro, M
    Tavazzi, D
    Bianchi, P
    Fermo, E
    Vercellati, C
    Zanella, A
    [J]. BLOOD, 2003, 102 (11) : 258A - 258A